Abbott’s new test is the fastest available molecular point-of-care test for the diagnosis of covid-19, delivering positive results in as little as 5 minutes and negative results in 13 minutes.
Read More
The agency’s EUA grants permission for Cepheid’s test to be used in high- and moderate-complexity CLIA-certified laboratories as well as in certain patient care settings.
Read MoreBuilding upon the existing Accula molecular platform, Mesa’s coronavirus test aims to deliver accurate and accessible testing close to the patient, providing critical information to healthcare providers in China, the United States, and other affected countries
Read More
The POC test would immediately help prostate cancer patients who have undergone radical prostatectomy but have positive surgical margins.
Read More
The visually read tests deliver up to 1,000-fold improvement in sensitivity to support surveillance and elimination efforts against global epidemics.
Read More